Skip to main content
S 2989 110th Congress Senate Health Artificial intelligence Biomedical engineering Brain Brain diseases Commerce Commercialization Department of Health and Human Services Drug approvals Economic impact statements Economics and Public Finance Executive reorganization Federal advisory bodies Federal aid to research Government Operations and Politics Governmental investigations Medical ethics Medical research Medical technology National Institutes of Health (NIH)

National Neurotechnology Initiative Act

Introduced: May 7, 2008 Introduced by: Murray, Patty Democratic · Washington See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 7, 2008
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 7, 2008
Sponsor introductory remarks on measure. (CR S3899-3900)
May 7, 2008
Introduced in Senate
 Plain-English summary Congressional Research Service

National Neurotechnology Initiative Act - Defines "neurotechnology" to mean the science and technology that allows an individual to analyze, understand, treat, and heal the brain and nervous system.

Requires the Secretary of Health and Human Services to implement a National Neurotechnology Initiative, under which the Secretary shall: (1) establish goals, priorities, and metrics for evaluation for federal neurotechnology research, development, and commercialization; (2) increase the investment in federal research, development, and translational programs in neurotechnology to achieve such goals; and (3) increase interagency coordination.

Requires the Secretary to establish the National Neurotechnology Coordination Office and the National Neurotechnology Advisory Council.

Requires the Director of the National Institutes of Health (NIH) to develop the Blueprint for Neuroscience Research to: (1) identify pervasive challenges in neuroscience and any technological barriers to solving such challenges; and (2) support the development of new tools, training opportunities, and other resources to assist neuroscientists in basic and clinical research.

Directs the Commissioner of Food and Drugs to require the Directors of the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health to improve the timelines of the review process for neurology and psychiatry.

Requires the Director of the National Neurotechnology Coordination Office to establish the American Neurotechnology Study Center.

What's happening now May 7, 2008

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1